Accounting reportsPreviously
|
Name | AKTSIONERNOE OBSCHESTVO "MEDSIL" |
---|
INN | 5029013989 |
---|
KPP | 502901001 |
---|
OGRN | 1025003518561 |
---|
OKPO | 18037666 |
---|
FFSM | 29600-H |
---|
Address | 141018, Moskovskaya Oblast', g.o. Mytischi, g. Mytischi, pr-kt Novomytischinskiy, d. D. 41A, of. POMESCH. II/1 |
---|
Phone | +7 (985) 769-22-88 Contact details |
|
OKVED code | Type | Name of activity type |
---|
26.60.4 | Core activity | Manufacture of tools, equipment and devices used for medical purposes | 22.19.2 | Additional activity | Production of rubber mixtures and articles thereof; manufacturing vulcanized rubber in the form of threads, cords, plates, sheets, bars, rods and profiles | 22.19.3 | Additional activity | Production of pipes, tubes, hoses and hoses of vulcanised rubber | All types of activities | 22.29.2 | Additional activity | Manufacture of other plastic products not included in other groupings | 27.90 | Additional activity | Manufacture of other electrical equipment | 46.46.2 | Additional activity | Wholesale of medical and orthopedic goods, dental and laboratory supplies | 46.90 | Additional activity | Nonspecialised wholesale trade | 72.19 | Additional activity | Research and experimental development on natural sciences and engineering Other |
Registration date | 25.09.2002 |
---|
Registering department | Moskovskaya oblastnaya registratsionnaya palata |
---|
|
AO "MEDSIL" (Moscow Oblast; INN 5029013989) was registered on 25 Sep 2002. The company's authorized capital as of July 1, 2012 was 300 rub. Type of ownership of AO "MEDSIL" - Closed joint-stock companies. Form of ownership of AO "MEDSIL" - Private property. Principal activities of AO "MEDSIL": manufacture of tools, equipment and devices used for medical purposes (26.60.4), production of rubber mixtures and articles thereof; manufacturing vulcanized rubber in the form of threads, cords, plates, sheets, bars, rods and profiles (22.19.2), production of pipes, tubes, hoses and hoses of vulcanised rubber (22.19.3). |
Economic indicators2021
Net profit (RAS) of AO MEDSIL grew over 2021 1.53 times to 98.42 million RUB from 64.38 million RUB over 2020, the company informed. Revenue increased in the accounting period by 12.76% to 690.69 million RUB from 612.55 million RUB over 2020; cost of goods sold remained at the same level amounting to 199.51 million RUB compared to 200.46 million RUB; sales profit went up 2.15 times to 132.77 million RUB from 61.75 million RUB. 2020
Net profit (RAS) of AO MEDSIL grew over 2020 3.27 times to 64.38 million RUB from 19.71 million RUB over 2019, the company informed. Revenue increased in the accounting period by 13.14% to 612.55 million RUB from 541.40 million RUB over 2019; cost of goods sold grew by 2.63% to 200.46 million RUB from 195.32 million RUB; sales profit went up by 34.24% to 61.75 million RUB from 46.00 million RUB. 2019
Net profit (RAS) of AO MEDSIL grew over 2019 by 29.16% to 19.71 million RUB from 15.26 million RUB over 2018, the company informed. Revenue increased in the accounting period by 12.50% to 541.40 million RUB from 481.24 million RUB over 2018; cost of goods sold grew by 4.66% to 195.32 million RUB from 186.61 million RUB; sales profit went up 2.47 times to 46.00 million RUB from 18.60 million RUB. 2018
Net profit (RAS) of AO MEDSIL dropped in 2018 by 48.90% to 15.26 million RUB from 29.87 million RUB over the same period in 2017, the company informed. Revenue increased in the accounting period by 22.92% to 481.24 million RUB from 391.52 million RUB over 2017; cost of goods sold grew by 29.13% to 186.61 million RUB from 144.51 million RUB; sales profit fell 2.67 times to 18.60 million RUB from 49.71 million RUB. 2017
Net profit (RAS) of AO MEDSIL grew over 2017 2.60 times to 29.87 million RUB from 11.51 million RUB over 2016, the company informed. Revenue increased in the accounting period by 8.38% to 391.52 million RUB from 361.26 million RUB over 2016; cost of goods sold decreased by 4.60% to 144.51 million RUB from 151.48 million RUB; sales profit went up 1.67 times to 49.71 million RUB from 29.83 million RUB. 2016
Net profit (RAS) of AO MEDSIL dropped in 2016 by 24.85% to 11.51 million RUB from 15.31 million RUB over the same period in 2015, the company informed. Revenue increased in the accounting period by 22.15% to 361.26 million RUB from 295.74 million RUB over 2015; cost of goods sold grew by 14.26% to 151.48 million RUB from 132.58 million RUB; sales profit went up 1.54 times to 29.83 million RUB from 19.33 million RUB. 2014
Net profit (RAS) of MEDSIL, ZAO grew over 2014 by 3.03% to 12.97 million RUB from 12.59 million RUB over 2013, the company informed. Revenue increased in the accounting period by 3.00% to 281.48 million RUB from 273.29 million RUB over 2013; cost of goods sold decreased by 1.44% to 122.74 million RUB from 124.54 million RUB; sales profit fell 2.17 times to 9.61 million RUB from 20.89 million RUB. 2013
Net profit (RAS) of MedSil, ZAO grew over 2013 by 42.31% to 12.59 million RUB from 8.85 million RUB over 2012, the company informed. Revenue increased in the accounting period by 16.89% to 273.29 million RUB from 233.79 million RUB over 2012; cost of goods sold grew by 28.01% to 124.54 million RUB from 97.29 million RUB; sales profit went up by 45.13% to 20.89 million RUB from 14.39 million RUB. 2012
Net profit (RAS) of MedSil, ZAO grew over 2012 3.41 times to 8.85 million RUB from 2.60 million RUB over 2011, the company informed. Revenue increased in the accounting period by 35.48% to 233.79 million RUB from 172.56 million RUB over 2011; cost of goods sold grew by 31.77% to 219.39 million RUB from 166.50 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|